According to guidelines, should a repeat endoscopy be performed after a standard course of proton‑pump inhibitor therapy for Los Angeles grade B erosive esophagitis in an otherwise typical adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Repeat Endoscopy for LA Grade B Esophagitis After PPI Therapy

No, repeat endoscopy is NOT recommended for Los Angeles grade B esophagitis after PPI therapy in typical cases. Guidelines explicitly reserve follow-up endoscopy only for severe erosive esophagitis (LA grades C and D), not for grade B disease 1, 2.

Guideline-Based Recommendations

When Repeat Endoscopy IS Required

  • LA Grade C or D esophagitis only: The AGA Clinical Practice Update (2022) clearly states that "a relook endoscopy is only needed for those with Los Angeles Grade C and D esophagitis" 1.
  • Purpose of repeat endoscopy in severe disease: To document healing of esophagitis, assess for features of malignancy, and evaluate for underlying Barrett's esophagus, which may be present in 10-12% of patients with severe esophagitis 1.
  • Timing: After 8 weeks of twice-daily PPI therapy 1, 2.

When Repeat Endoscopy IS NOT Required

  • LA Grade A or B esophagitis: The American College of Physicians (2012) states that patients with documented severe erosive esophagitis (grade B or worse) warrant follow-up endoscopy, but this recommendation specifically targets the more severe end of grade B disease in the context of Barrett's screening 2.
  • The most recent AGA guidance (2022) clarifies this further by explicitly limiting repeat endoscopy to grades C and D only 1.

Clinical Algorithm for LA Grade B Esophagitis

Initial Management

  1. Treat with PPI therapy: Standard once-daily dosing for 4-8 weeks initially 2.
  2. Escalate if needed: Twice-daily PPI if once-daily therapy unsuccessful 2.
  3. Optimize timing: PPIs should be taken 30-60 minutes before meals for optimal efficacy 2, 3.

Follow-Up Strategy

  • Symptom-based management: If symptoms resolve, continue maintenance PPI at lowest effective dose 4.
  • No routine repeat endoscopy: For uncomplicated LA grade B esophagitis without alarm symptoms 1.
  • Taper to lowest effective dose: Once adequate response achieved 4.

Exceptions Requiring Repeat Endoscopy

Specific Clinical Scenarios

  • Alarm symptoms present: Dysphagia, bleeding, anemia, weight loss, or recurrent vomiting warrant repeat endoscopy regardless of LA grade 2.
  • Concern for dysplasia or malignancy: If concerning endoscopic findings noted at initial endoscopy, biopsy and repeat endoscopy after 8 weeks of twice-daily PPI is appropriate 1.
  • Persistent symptoms despite adequate PPI therapy: Consider repeat endoscopy to evaluate for incomplete healing or alternative diagnoses 2, 4.
  • Documented stricture: Symptom-based repeat endoscopy with dilation may be required 2.

Evidence Supporting Conservative Approach

Real-World Outcomes

  • Natural history is benign: Research demonstrates that the majority of patients with LA grade A or B esophagitis show healing at follow-up endoscopy regardless of continued PPI use 5.
  • No progression to severe disease: Studies show no patients with grade B esophagitis progressed to more severe grades 5.
  • Barrett's risk is low: The rate of Barrett's esophagus in LA grade A/B esophagitis is approximately 5%, compared to 14% in grade C (though this difference was not statistically significant in one study) 5.
  • Grade A/B and absence of hiatal hernia predict healing: These are independent predictors of esophagitis healing on multivariate analysis 5.

Healing Rates Without Repeat Endoscopy

  • High healing rates with PPI: Even in real-world settings, remission rates for grade B esophagitis with PPI therapy are substantial 6.
  • Symptom resolution correlates with healing: Resolution of symptoms like dysphagia is associated with 90% healing rates across PPI treatments 7.

Common Pitfalls to Avoid

Over-Testing

  • Unnecessary repeat endoscopy: Performing routine follow-up endoscopy for LA grade B esophagitis increases costs and procedural risks without clear benefit in typical cases 1.
  • Confusing grade B with severe disease: Grade B is considered mild-to-moderate erosive esophagitis, not severe disease requiring mandatory follow-up 1, 5.

Under-Recognition of High-Risk Features

  • Missing alarm symptoms: Persistent dysphagia despite PPI therapy may indicate failed healing and warrants repeat endoscopy 7.
  • Ignoring large hiatal hernia: Presence of hiatal hernia is associated with lower healing rates and may warrant closer follow-up 5.
  • Failing to document Barrett's screening: If initial endoscopy showed active inflammation preventing adequate Barrett's assessment, consider repeat endoscopy after healing in high-risk patients (men >50 years with chronic GERD symptoms) 2.

Special Considerations

Barrett's Esophagus Screening Context

  • If Barrett's screening is the goal: The presence of erosive esophagitis may prevent detection of underlying Barrett's esophagus 8.
  • Consider repeat endoscopy after healing: Approximately 12% of patients with healed erosive esophagitis are found to have Barrett's esophagus (mainly short-segment) on repeat endoscopy 8.
  • This applies primarily to high-risk patients: Men older than 50 years with chronic GERD symptoms 2.

When Biopsies Were Obtained at Initial Endoscopy

  • If dysplasia suspected: Repeat endoscopy after 8-12 weeks of twice-daily PPI is mandatory to confirm findings and exclude inflammation-related over-diagnosis 9.
  • Active inflammation affects pathology: Surveillance biopsies should ideally not be performed in the presence of active inflammation (LA grades C and D specifically mentioned, but principle applies to obtaining accurate pathology) 9.

References

Guideline

Treatment of Grade B Esophagitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Dysphagia in patients with erosive esophagitis: prevalence, severity, and response to proton pump inhibitor treatment.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2004

Related Questions

What is the recommended proton pump inhibitor (PPI) dosing for the treatment of erosive esophagitis?
Can Los Angeles grade A and B erosive esophagitis progress to neoplasia?
What is the outpatient management of esophagitis?
What is the typical duration of treatment with twice-daily (bid) Proton Pump Inhibitor (PPI) for esophagitis?
Is it justified to repeat endoscopy in a patient with persistent symptoms, diagnosed with erosive gastritis within the past 6 months, despite initial treatment with medications such as Proton Pump Inhibitors (PPIs)?
Can telmisartan and amlodipine be used together to control blood pressure in a patient with pheochromocytoma who has already been adequately alpha‑blocked?
What is the recommended dosing of double‑strength Bactrim (trimethoprim 160 mg/sulfamethoxazole 800 mg) for adults, when is a double‑dose regimen indicated, and how should the dose be adjusted for renal impairment, elderly patients, and children?
What is the recommended dosing of Keflex (cephalexin) for an otherwise healthy adult with a mild‑to‑moderate infection, including pediatric weight‑based dosing, adjustments for impaired renal function, contraindications, and monitoring?
How should a povidone‑iodine gargle be prepared and used safely, including concentration, dose, frequency, duration, and contraindications?
What are the nutritional recommendations (calorie intake, protein, calcium, vitamin D, and other micronutrients) for an adult patient with a fracture, including adjustments for older age or chronic kidney disease?
A patient presents with abrupt fever, severe headache, myalgias, dry cough, and recent exposure to parrots; what is the most likely diagnosis and the recommended first‑line treatment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.